Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
Department of Cardiovascular Disease, First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
Biomed Pharmacother. 2020 May;125:110015. doi: 10.1016/j.biopha.2020.110015. Epub 2020 Feb 27.
To assess geniposide's effects in New Zealand rabbits with high-fat diet induced atherosclerosis and to explore the underpinning mechanisms.
Aorta histological changes were evaluated by intravenous ultrasound (IVUS) and H&E staining. Lipid accumulation in the aortic was quantified by Oil Red O staining. Then, RNA sequencing (RNA-seq) was carried out for detecting differentially expressed genes in rabbit high-fat diet induced atherosclerosis. The levels of the cytokines CRP, IL-1β and IL-10 were determined by ELISA. Protein levels of iNOS and Arg-1 were assessed by Western blot and immunohistochemical staining. The mRNA expression levels of NR4A1, CD14, FOS, IL1A, iNOS and Arg-1 were detected by quantitative real-time PCR (qPCR).
Geniposide markedly reduced the degree of atherosclerotic lesions in aorta tissues. RNA-seq and qPCR demonstrated that NR4A1, CD14, FOS and IL1A mRNA amounts were overtly increased in New Zealand rabbits with high-fat diet induced atherosclerosis. Moreover, geniposide reduced iNOS (M1 phenotype) mRNA and protein amounts as well as IL-1β secretion, which were enhanced in New Zealand rabbits with high-fat diet induced atherosclerosis. Besides, Arg-1 (M2 phenotype) mRNA and protein amounts were significantly increased after geniposide treatment, as well as IL-10 secretion.
These findings suggest that geniposide could inhibit the progression of and stabilize atherosclerotic plaques in rabbits by suppressing M1 macrophage polarization and promoting M2 polarization through the FOS/MAPK signaling pathway.
评估京尼平苷在新西兰兔高脂饮食诱导的动脉粥样硬化中的作用,并探讨其作用机制。
通过静脉超声(IVUS)和 H&E 染色评估主动脉组织学变化。油红 O 染色定量检测主动脉脂质堆积。然后,进行 RNA 测序(RNA-seq),以检测兔高脂饮食诱导的动脉粥样硬化中差异表达的基因。通过 ELISA 检测 CRP、IL-1β 和 IL-10 细胞因子水平。通过 Western blot 和免疫组化染色评估 iNOS 和 Arg-1 蛋白水平。通过实时定量 PCR(qPCR)检测 NR4A1、CD14、FOS、IL1A、iNOS 和 Arg-1 的 mRNA 表达水平。
京尼平苷显著减轻了主动脉组织中动脉粥样硬化病变的程度。RNA-seq 和 qPCR 结果表明,NR4A1、CD14、FOS 和 IL1A mRNA 水平在新西兰兔高脂饮食诱导的动脉粥样硬化中明显增加。此外,京尼平苷降低了新西兰兔高脂饮食诱导的动脉粥样硬化中 iNOS(M1 表型)mRNA 和蛋白水平以及 IL-1β 的分泌。同时,京尼平苷处理后 Arg-1(M2 表型)mRNA 和蛋白水平显著增加,IL-10 分泌也增加。
这些发现表明,京尼平苷通过抑制 M1 巨噬细胞极化和促进 FOS/MAPK 信号通路的 M2 极化,可抑制兔动脉粥样硬化的进展并稳定动脉粥样硬化斑块。